Table 7 Comparison of age between different groups of COVID-19 patients with and without heart disease and healthy participants (control).

From: Association of DHEAS levels with COVID19 severity, gender, age, comorbidities, and management strategies

 

Age (years)

N

Mean ± SD

Median

Q1

Q3

p.value1

p.value2

p.value3

p.value4

1

MD Positive/ Patient

131

61 ± 13

60

52

70

    

2

MD Negative / Patient

467

47 ± 16

45

34

58

< 0.001

   

3

MD Negative / Control

64

45 ± 14

46

35

56

< 0.001

0.374

  

1

MD Positive / Inpatient

100

62 ± 12

61

53

70

    

2

MD Positive / Outpatient

31

57 ± 14

56

50

66

0.087

   

3

MD Negative / Inpatient

246

53 ± 17

50

39

66

< 0.001

0.144

  

4

MD Negative / Outpatient

221

41 ± 13

38

31

50

< 0.001

< 0.001

< 0.001

 

5

MD Negative / Control

64

45 ± 14

46

35

56

< 0.001

< 0.001

0.001

0.019

1

MD Positive / patient

Female

69

60 ± 13

60

52

69

    

Male

62

62 ± 12

60

54

70

0.337

   

2

MD Negative / patient

Female

186

47 ± 16

45

33

59

    

Male

281

47 ± 16

45

35

57

0.728

   

3

MD Negative / control

Female

24

41 ± 12

41

32

53

    

Male

40

44 ± 14

42

33

55

0.303

   
  1. P-value 1 compares group1 with other groups and p-value 2 compares group 2 with other groups. P-value 3 compares group 3 with other groups. P-value 4 compares group 4 with group 5. P-value < = 0.05 is significant.
Back to article page